News

Published on 6 Dec 2024 on Insider Monkey · via Yahoo Finance

ResMed (RMD) Rose 15% in Q3

Article preview image

Fidelity Investments, an investment management company, recently released its “Fidelity Growth Strategies Fund” third quarter 2024 investor letter. A...

Read the rest of the article
NYSE.RMD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
With 74% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst...

Key Insights Given the large stake in the stock by institutions, ResMed's stock price might be...

Simply Wall St. · via Yahoo Finance 18 Dec 2024
ZBH Stock Might Rise Following FDA Nod for OsseoFit

Rank and Key Picks ZBH currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the...

Zacks · via Yahoo Finance 16 Dec 2024
Why ResMed (RMD) is a Top Value Stock for the Long-Term

Utilizing ratios like P/E, PEG, Price/Sales, and Price...Flow, the Value Style Score identifies t...

Zacks · via Yahoo Finance 13 Dec 2024
Zacks.com featured highlights include InterDigital, ResMed, Greenbrier...

December 13, 2024 – Stocks in this week’s article are InterDigital, Inc. (IDCC Quick QuoteIDCC -...

Zacks 13 Dec 2024
Top Research Reports for Berkshire Hathaway, Exxon Mobil & Novo Nordisk

Today's Research Daily features new research reports on 16 major stocks, including Berkshire...

Zacks · via Yahoo Finance 6 Dec 2024
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Why This 1 Growth Stock Should Be On Your Watchlist For growth investors, a company...like projec...

Zacks · via Yahoo Finance 6 Dec 2024
Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

The expansion of gross and operating margins on a reported basis bodes well for the stock. Improv...

Zacks · via Yahoo Finance 6 Dec 2024
ResMed (RMD) Rose 15% in Q3

Fidelity Investments, an investment management company, recently released its “Fidelity Growth St...

Insider Monkey · via Yahoo Finance 6 Dec 2024
ResMed director Peter C. Farrell sells $491,300 in stock By Investing.com

ResMed, with a market capitalization of $35.1 billion, has demonstrated strong performance with a...

Investing.com 6 Dec 2024
ZBH Stock Might Rise Following FDA Nod for Knee Implant Component

Zimmer Biomet's Persona SoluTion Porous Plasma Spray Femur gets FDA 510(k) approval. The company...

Zacks · via Yahoo Finance 5 Dec 2024

Copyright Statfolio @ 2024

Social Accounts